找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Keratoprostheses and Artificial Corneas; Fundamentals and Sur M. Soledad Cortina,Jose de la Cruz Book 2015 Springer-Verlag Berlin Heidelber

[復制鏈接]
樓主: 銀河
11#
發(fā)表于 2025-3-23 13:18:11 | 只看該作者
Management of Glaucoma Associated with Boston KPro Type I Implantationsurgery and is associated with poorer postoperative outcomes. Pathophysiologic factors include underlying disease process, synechial angle closure, steroid-response intraocular pressure (IOP) elevation, and possible pupillary block. Frequent monitoring with structural and functional testing measures
12#
發(fā)表于 2025-3-23 14:06:27 | 只看該作者
Boston KPro Type 1: The Role of the Contact Lensafter surgery is a Kontur? Precision Sphere with a 16.0 mm diameter, 9.8 mm base curve, and plano power. Proper centration of the lens and complete corneal coverage are essential for a proper fit, lens retention, and ocular protection. Over-refraction should be measured at each visit and power chang
13#
發(fā)表于 2025-3-23 21:20:18 | 只看該作者
Boston KPro Type I: Vitreoretinal Considerations. As the use of KPro increases dramatically, so too does the frequency of posterior segment complications seen by the vitreoretinal surgeon in this patient population, as well as the importance of addressing them expeditiously. Special consideration in diagnostic imaging and surgical planning is req
14#
發(fā)表于 2025-3-24 02:02:54 | 只看該作者
15#
發(fā)表于 2025-3-24 03:35:37 | 只看該作者
Keratoprostheses in the Setting of Autoimmune Disorderstions including keratoprostheses. The most challenging of this subset of patients to treat are those with corneal blindness due to autoimmune diseases. Studies have suggested that these patients respond poorly to transplantation due to alterations in corneal tissue at the level of the cellular, micr
16#
發(fā)表于 2025-3-24 08:56:46 | 只看該作者
17#
發(fā)表于 2025-3-24 13:07:43 | 只看該作者
José L. Güell MD, PhD,Elena Arrondo,M. Soledad Cortina MD,Jaime Echevarría,Maria V. Gómez-Resa,Oscarular. We establish the correspondence between evidence-based health care and translational effectiveness, which, as defined by AHRQ, represents the utilization of the best available evidence in clinical settings. We discuss the process of evidence-based health care and translational effectiveness in
18#
發(fā)表于 2025-3-24 17:11:33 | 只看該作者
Ahmad A. Aref MD,Thasarat S. Vajaranant MDcondition (diagnosis) (.., prevalence, sensitivity, specificity) or from monitoring its course (i.e., prognosis) (.., prevalence and relative prevalence in cross-sectional observation studies, incidence in cohort studies, and experimental designs including clinical trials). The process of quantifica
19#
發(fā)表于 2025-3-24 21:58:55 | 只看該作者
20#
發(fā)表于 2025-3-24 23:38:10 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 22:54
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
滁州市| 陆川县| 如东县| 湛江市| 中超| 台东市| 龙江县| 衡南县| 浦县| 安多县| 平利县| 搜索| 鄂伦春自治旗| 阿拉善盟| 香河县| 卓尼县| 理塘县| 施秉县| 金昌市| 瓮安县| 灵璧县| 高阳县| 富裕县| 南郑县| 昌江| 湖南省| 武清区| 开封县| 温宿县| 忻城县| 集安市| 都昌县| 东莞市| 普洱| 襄汾县| 安平县| 兴城市| 灌南县| 凤台县| 来安县| 卢龙县|